The Fridley-based company makes cardiovascular, cardiac rhythm, neurological, spinal, diabetes and surgical medical device technologies and therapies.

63.59 USD  -0.51 (-0.80%)
Delayed Price  /  Updated: 5:55 PM CDT, Aug 22, 2014  /  Add to My Watchlist      
52 Week High 65.50
52 Week Low 51.22
Volume 5146175
Bid (Size) 1200
Ask (Size) 6900
Today's Range 64.40 - 63.515
Shares Outstanding 996192332
Dividend Yield 1.145

key info

Follow Medtronic

Connect with facebook Connect with Linkedin

Related Companies

StarTribune 100

A measure of the largest publicly held companies with headquarters in Minnesota ranked by revenue.

star tribune coverage

Medtronic to press ahead with Covidien deal

ARTICLE Updated: Aug 22 2014 - 7:12 PM

Medtronic Inc. executives reaffirmed their commitment to move the company’s legal headquarters to Ireland through a corporate acquisition, despite public criticism and the threat of changes in...

Upset stockholders confront Medtronic executives

ARTICLE Updated: Aug 22 2014 - 4:04 PM

Medtronic Inc. chief executive Omar Ishrak heard an earful from stockholders who got their first chance Thursday to directly question the company’s planned purchase of an Irish...

Medtronic hires ex-senators to lobby bills that could kill Covidien deal

ARTICLE Updated: Aug 13 2014 - 6:53 AM

WASHINGTON – Medtronic Inc. has hired two former U.S. senators to lobby their ex-colleagues against legislation that could undermine the company’s plans to move its headquarters overseas...

Medtronic buys Visualase for $105 million

ARTICLE Updated: Jul 29 2014 - 8:47 AM

Medtronic Inc. said Monday it will spend up to $105 million to buy Visualase Inc., a small Texas company that has developed a system using an MRI-guided laser for minimally invasive...

Schafer: St. Jude stays course after rival's huge deal

ARTICLE Updated: Jul 19 2014 - 4:20 PM

Medtronic’s planned acquisition of Covidien, a $43 billion deal that should have shaken the ground plenty hard under the feet of St. Jude Medical’s executives, hasn’t had that much...

See all content

executive compensation

Omar Ishrak

Chm., CEO

Current year rank 13
Current year compensation $8,331,159
Percent change of the CEO 33.0

See more state CEO pay packages

executive team

  • Omar Ishrak, Chairman and CEO
  • Gary Ellis, Senior Vice President and CFO
  • Cameron Findlay, Senior Vice President and General Counsel
  • Michael Coyle, Executive Vice President and Group President, Cardiac and Vascular

twitter feed

business blogbusiness blog

3D Economics

What are the forces moving the Minnesota economy? Adam Belz tries to identify the trends and show the connections between...

minnesota topics minnesota topics

Minnesota Topics are a comprehensive collection of Star Tribune content on select people, places and companies.